Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: November 2007
-
As reported earlier this month on Patent Docs, the biotechnology, chemical, and pharmaceutical technology groups at the USPTO will hold the next quarterly meeting next Tuesday, December 4, 2007. The Patent Office has posted the official announcement which includes the list of topics and speakers: Morning Session (9:00-noon EST): Greeting and Overview Invention Secrecy Program…
-
American Conference Institute (ACI) will be holding a conference on Pharma/Biotech Patent Claim Drafting and Prosecution on February 25-26, 2008 in New York, New York. The conference will provide information on: The status of Tafas v. Dudas and the fate of the U.S. Patent and Trademark Office's claims and continuation rules. Analyzing the interplay between…
-
Law Education Institute, Inc. (LEI) will be holding the 25th Annual National CLE Conference on January 4-8, 2008 in Vail, Colorado. The Intellectual Property program of the conference, which will be held at the Vail Marriott Resort and Spa, will offer presentations on a number of topics, including: Valuation of intellectual property. Declaratory judgment actions…
-
American Conference Institute (ACI) will be holding a conference on Strategic Intellectual Property Planning on February 25-26, 2008 in Scottsdale, Arizona. The conference will share insights on: Applying current legal and legislative trends to your IP practices. Identifying which IP protections are available. Using competitive intelligence to drive market and IP strategy. Improving contracting and…
-
By Robert Dailey — Section 255 of the Patent Act provides a mechanism for correcting typographical or minor errors in an issued patent. Whenever a mistake of a clerical or typographical nature, or of minor character, which was not the fault of the Patent and Trademark Office, appears in a patent and a…
-
By Suresh Pillai — Metagenics, Inc. of San Clemente, California has been awarded U.S. Patent Nos. 7,270,835 ("Compositions that treat or inhibit pathological conditions associated with inflammatory response," issued September 18, 2007); 7,195,785 ("Complex mixtures exhibiting selective inhibition of cyclooxygenase-2," issued March 27, 2007) and 7,205,151 (same title, issued April 17, 2007), three…
-
By Jason Derry — Exiqon A/S and Oncotech Inc. have announced that Exiqon will acquire Oncotech for approximately $45 million. Oncotech provides diagnostic tests that help physicians optimize treatment regimens for cancer patients. Exiqon provides a number of products to assist in analyzing gene expression, including microRNA profiling products and services. Through the…
-
By Christopher P. Singer — In a November 26, 2007 press release, InterMune Inc. announced that it will purchase patent rights to pirfenidone from Marnac, Inc. and KDL GmbH. This acquisition includes patent rights that InterMune had been licensing from Marnac and KDL as well as other international IP rights relating to pirfenidone…
-
By Sherri Oslick — Astellas Pharma Inc. of Tokyo, has announced an agreement between its U.S. subsidiary, Astellas U.S. Holding of Deerfield, IL and Agensys, Inc. of Santa Monica CA under which Astellas will acquire Agensys for $387 million in cash, with up to an additional $150 million dependent upon Agensys’ achievement of…
-
By Sherri Oslick — GlaxoSmithKline of London, UK and Philadelphia, PA and Reliant Pharmaceuticals of Liberty Corner, NJ have announced an agreement under which GSK will acquire Reliant for $1.65 billion in cash. Reliant is a privately held pharmaceutical company focused on cardiovascular therapeutics. Reliant’s therapeutic portfolio has been developed through in-licensing and…
Patent Docs 